Public Library of Science
Browse
DOCUMENT
Figure_S1.pdf (113.04 kB)
DOCUMENT
Figure_S2.pdf (291.04 kB)
DOCUMENT
Figure_S3.pdf (171.85 kB)
DOCUMENT
Figure_S4.pdf (656.08 kB)
DOCUMENT
Figure_S5.pdf (1.56 MB)
DOCUMENT
Figure_S6.pdf (634.34 kB)
DOCUMENT
Figure_S7.pdf (223.71 kB)
DOCUMENT
Table_S1.pdf (40.86 kB)
1/0
8 files

Inhibition of the TRAIL Death Receptor by CMV Reveals Its Importance in NK Cell-Mediated Antiviral Defense

dataset
posted on 2014-08-14, 09:36 authored by Shilpi Verma, Andrea Loewendorf, Qiao Wang, Bryan McDonald, Alec Redwood, Chris A. Benedict

TNF-related apoptosis inducing ligand (TRAIL) death receptors (DR) regulate apoptosis and inflammation, but their role in antiviral defense is poorly understood. Cytomegaloviruses (CMV) encode many immune-modulatory genes that shape host immunity, and they utilize multiple strategies to target the TNF-family cytokines. Here we show that the m166 open reading frame (orf) of mouse CMV (MCMV) is strictly required to inhibit expression of TRAIL-DR in infected cells. An MCMV mutant lacking m166 expression (m166stop) is severely compromised for replication in vivo, most notably in the liver, and depleting natural killer (NK) cells, or infecting TRAIL-DR−/− mice, restored MCMV-m166stop replication completely. These results highlight the critical importance for CMV to have evolved a strategy to inhibit TRAIL-DR signaling to thwart NK-mediated defenses.

History

Usage metrics

    PLOS Pathogens

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC